SKShuhei Kondo

Shuhei Kondo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuhei Kondo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Case of Anterior Mediastinal Hodgkin Lymphoma Exhibiting Abundant Intratumoral Vascular Structures on Computed Tomography

    by Ibuki Namihira, Motohiko Yamazaki, Yukari Goto, Yuma Fuzawa, Masaki Tominaga, Takuya Yagi, Yusuke Tani, Shuhei Kondo, Hajime Umezu, Hiroyuki Ishikawa

    Hodgkin lymphoma shows a bimodal age distribution, predominantly affecting young adults and individuals in their 50s and 60s, and is the most common type of lymphoma occurring in the mediastinum. Typical computed tomography (CT) imaging findings include a bulky mass arising in the anterior mediastinum (prevascular compartment) with homogeneous soft-tissue attenuation. Herein, we report a case with unusual CT findings characterized by abundant internal vascular structures in an 18-year-old man with nodular sclerosis classic Hodgkin lymphoma who presented with hemoptysis. Histopathologic examination revealed numerous dilated capillaries within the lesion, which were consistent with the CT findings. Reports of mediastinal lymphoma accompanied by such prominent vascular structures are extremely rare.

  • Open Access

    Small Bowel Gastrointestinal Stromal Tumors: A 15-Year Cohort Study Focusing on Jejuno-Ileal Site-Specific Outcomes and Prognostic Factors

    by Yuichi Kojima, Kentaro Tominaga, Yuzo Kawata, Chizuru Kaneko, Shuhei Kondo, Yoshifumi Shimada, Junji Yokoyama, Toshifumi Wakai, Shuji Terai

    Background: Site-specific long-term outcomes, including neurofibromatosis type 1 (NF1), Ki-67 prognostic value, and very late recurrences of small bowel gastrointestinal stromal tumors (GISTs), remain inadequately defined. Methods: This retrospective cohort study investigated the clinical characteristics, diagnostic challenges, and long-term outcomes of patients with small bowel GISTs. This retrospective, single-center study (2008–2024) analyzed 27 consecutive patients (average age: 62.2 years) with jejunal/ileal GISTs. Clinicopathologic features, diagnostic yield of balloon-assisted enteroscopy (BAE), treatments, and outcomes were evaluated during a 10.2-year median follow-up period. Recurrence-free survival (RFS) and overall survival (OS) were estimated by Kaplan–Meier with log-rank testing. Ki-67 was assessed using MIB-1; a prespecified 5% cut-off was chosen based on prior evidence. Results: Tumor (mean size, 62.4 mm) sites included the jejunum (74.1%) and ileum (25.9%). NF1 was present in 3/27 (11.1%) patients, all with multiple jejunal tumors. Among the 14 patients who underwent BAE, biopsy was attempted in six and yielded a histological diagnosis in one (16.7%). Six patients had recurrence; two died from disease >10 years postoperatively. Five-year OS and RFS were 91.3% and 68.7%, respectively. Adverse RFS was associated with ileal location (p = 0.03), size ≥ 10 cm (p < 0.001), mitoses > 5/50 high-power fields (p = 0.002), and Ki-67 ≥ 5% (p < 0.001). One patient labeled low risk by conventional models had recurrence with Ki-67 = 10%. Another classified as low risk by conventional models experienced recurrence >10 years after surgery, with a Ki-67 index of 10%. Conclusions: Extended, risk-adapted surveillance may be reasonable for small-bowel GISTs, and it may be beneficial to incorporate Ki-67 (≥5%) into site-based risk stratification. These observations remain hypothesis-generating and require validation in larger, multicenter cohorts and prospective studies.